EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed medical diagnostics business, announces that a general meeting of the Company will be held at the offices of Harwood Capital LLP, 6 Stratton Street, Mayfair, London W1J 8LD at 11:00 a.m. on 27th July 2017 (the "General Meeting") for the purpose of considering and, if thought fit, approving resolutions to cancel the share premium reserve of the Company and to grant the Company the general authority to make market purchases of its own shares.
The cancellation is necessary in order for the Company to proceed with its previously announced share buyback plan of up to 15% of the Company’s current issued share capital.
A copy of a circular containing the notice convening the General Meeting and form of proxy will be posted to shareholders later today and will shortly be available on the Company's website, www.ekfdiagnostics.com in accordance with AIM Rule 20 or can be downloaded here.
|EKF Diagnostics Holdings plc
Julian Baines, CEO
Richard Evans, Finance Director and COO
Tel: 00 44 29 2071 0570
|N+1 Singer (Nomad & Broker)
Alex Price / Shaun Dobson / Ali Laughton-Scott
|Tel: 020 7496 3000
Walbrook PR Limited
|Tel: 020 7933 8780 or
Mob: 07980 541 893 / 07584 391 303